QIM
CLDX icon

Quantitative Investment Management’s Celldex Therapeutics CLDX Stock Holding History

Quantitative Investment Management’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,620
Closed -$238K – 690
2016
Q2 		$238K Sell
3,620
-13,293
-79% -$844K 0.01% 656
2016
Q1 		$958K Buy
+16,913
New +$1.9M 0.05% 405
2015
Q3 		– Sell
-573
Closed -$216K – 693
2015
Q2 		$216K Sell
573
-1,294
-69% -$514K 0.03% 370
2015
Q1 		$780K Buy
+1,867
New +$668K 0.07% 245
2014
Q2 		– Sell
-1,433
Closed -$379K – 482
2014
Q1 		$379K Buy
+1,433
New +$549K 0.02% 392

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return